The Four-Hit Hypothesis & The Role Of APRIL In IgA Nephropathy
The goal of this webinar is to provide a detailed overview of the Four-Hit hypothesis as well as explain the role of APRIL in disease pathogenesis.
- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Attend live and virtual events that provide a platform for education and collaborative discussion about the management of kidney disease and strategies to improve kidney health.
Any NephU member can request a presentation for their region or organization at no charge.
Featured Events
Events
Webinar
Utilization Of The International IgA Nephropathy Prediction Tool
Learn about the clinical, laboratory and histological risk predictors that make up the International IgAN Prediction Tool and gain an understanding of its clinical utility and future potential.
Cooking Demo: Dietary Considerations for Patients with IgA Nephropathy
Registered Dietitian Lauren Levy and Kidney-Friendly Chef Anthony Valentine come together to bring their expertise in nutrition and IgAN, including discussing the basics of nutritional concepts – such as sodium and protein – in patients with IgAN.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
